Linde Plc (LIN) Stock Forecast Oct. 14, 2026
Analysis updated on Oct. 14, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Linde Plc (LIN) stock forecast summary
Our AI ranks Linde Plc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Linde Plc is a mega-cap company with a market capitalization of $226.85B. It ranks number 1 by market capitalization among the 9 Industrial Inorganic Chemicals issuers in our coverage with a current forecast. Its P/B Ratio of 5.80x is the highest of the 9 peers that report one. Its ROE of 18.5% is the highest of the 9 peers that report one.
A per-ticker accuracy statistic for LIN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.2%, buy ≥ +0.5%, sell < -0.6%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-14 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, LIN included.
Follow LIN freeLIN price chart and AI forecast
How LIN ranks among 4004 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Linde Plc (LIN) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Industrial Inorganic Chemicals peers listed below that report each metric.
Valuation & Market
| Metric | LIN | Rank |
|---|---|---|
| Market Cap | $226.85B | 1/9 |
| P/E Ratio | 31.32x | – |
| P/B Ratio | 5.80x | 1/9 |
| Dividend Yield | 1.27% | 7/8 |
| EPS | $15.50 | – |
| Book Value/Share | $84.78 | – |
| Revenue/Share | $76.90 | – |
| FCF/Share | $10.79 | – |
Profitability & Margins
| Metric | LIN | Rank |
|---|---|---|
| ROE | 18.5% | 1/9 |
| ROA | 8.2% | 1/10 |
| ROIC | 13.0% | 2/10 |
| Gross Margin | 48.4% | 1/8 |
| Operating Margin | 26.4% | 1/9 |
| Net Margin | 20.4% | 1/9 |
| EBT Margin | 26.8% | 1/9 |
| Tax Rate | 21.9% | – |
Financial Health
| Metric | LIN | Rank |
|---|---|---|
| Current Ratio | 0.88x | 9/10 |
| Quick Ratio | 0.75x | 8/8 |
| D/E Ratio | 1.22x | 5/9 |
| Financial Leverage | 2.26x | 5/9 |
| Interest Coverage | 3.5x | 4/10 |
| Working Capital | -$1.95B | 10/10 |
Cash Flow
| Metric | LIN | Rank |
|---|---|---|
| Operating Cash Flow | $10.49B | 1/10 |
| Free Cash Flow | $4.97B | 1/7 |
| Capital Spending | -$5.51B | 7/7 |
| OCF Growth YoY | 5.8% | 3/5 |
| FCF Growth YoY | -1.9% | – |
| FCF/Sales | 14.0% | 1/7 |
| CapEx/Sales | 15.6% | 2/7 |
Operational Efficiency
| Metric | LIN | Rank |
|---|---|---|
| Asset Turnover | 0.40x | 6/8 |
| Receivables Turnover | 6.3x | 3/5 |
| Inventory Turnover | 8.6x | 2/7 |
| Fixed Assets Turnover | 1.2x | 7/8 |
| Days Sales Outstanding | 58 days | 3/5 |
| Days Inventory | 42 days | 6/7 |
| Payables Period | 57 days | 1/6 |
| Cash Conversion Cycle | 44 days | – |
Income Statement
| Metric | LIN | Rank |
|---|---|---|
| Total Revenue | $35.45B | 1/8 |
| Operating Income | $9.38B | 1/10 |
| Net Income | $7.24B | 1/10 |
| R&D Expense | $146M | 1/5 |
| SG&A Expense | $3.56B | 1/8 |
| Cost of Goods Sold | $18.31B | 1/7 |
Dividend & Shareholder Information
| Metric | LIN | Rank |
|---|---|---|
| Dividends Per Share | $6.24 | – |
| Payout Ratio | 40.3% | – |
| Shares Outstanding | 461M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $14.18B | 16.0% of assets |
| Cash & Short-term Investments | $4.90B | 5.5% of assets |
| Accounts Receivable | $5.63B | 6.4% of assets |
| Inventory | $2.12B | 2.4% of assets |
| Total Liabilities | $47.72B | 54.0% of assets |
| Short-term Debt | $13.29B | 15.0% of assets |
LIN quarterly financials and insider trading
Linde Plc (LIN) industry peers
Companies classified under the same SEC industry code as Linde Plc (Industrial Inorganic Chemicals): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| LIN Linde Plc | ▼ | $226.85B |
| APD Air Products & Chemicals, Inc. | ▶ | $64.35B |
| MTX Minerals Technologies Inc | ▼ | $1.99B |
| KRO Kronos Worldwide Inc | ▲ | $859M |
| TROX Tronox Holdings Plc | ▲ | $559M |
| LXFR Luxfer Holdings Plc | ▼ | $462M |
| VHI Valhi Inc /De/ | ▲ | $407M |
| NL Nli Holdings, Inc. | ▲ | $324M |
| LTBR Lightbridge Corp | ▶ | $211M |
| HGAS Global Gas Corp | ▲ | N/A |
Where LIN sits on the market map
Linde Plc (LIN) stock news
Loading...
Linde Plc (LIN) stock forecast FAQ
What is the Linde Plc (LIN) stock forecast?
Our AI ranks Linde Plc outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Linde Plc stock predictions?
A per-ticker accuracy statistic for LIN is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Linde Plc forecasts updated?
Linde Plc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 14, 2026.
Which companies are Linde Plc's industry peers?
10 issuers in our coverage, LIN included, share the SEC industry code Industrial Inorganic Chemicals. The largest are: Air Products & Chemicals, Inc. (APD), Minerals Technologies Inc (MTX), Kronos Worldwide Inc (KRO), Tronox Holdings Plc (TROX), Luxfer Holdings Plc (LXFR), Valhi Inc /De/ (VHI).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.